Clara Dong
Stock Analyst at Jefferies
(2.93)
# 3,086
Out of 4,444 analysts
23
Total ratings
50%
Success rate
7.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Clara Dong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintained: Buy | $44 → $45 | $17.32 | +159.82% | 2 | Feb 26, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $48 | $37.53 | +27.90% | 3 | Feb 18, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $28 | $9.85 | +184.26% | 2 | Feb 17, 2026 | |
| INCY Incyte | Maintained: Buy | $120 | $108.46 | +10.64% | 3 | Feb 11, 2026 | |
| GLUE Monte Rosa Therapeutics | Maintained: Buy | $31 | $20.85 | +48.68% | 1 | Jan 7, 2026 | |
| IBRX ImmunityBio | Maintained: Buy | $9 | $7.80 | +15.38% | 1 | Dec 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | $43 | $11.14 | +286.00% | 1 | Dec 10, 2025 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $73 → $122 | $99.87 | +22.16% | 2 | Dec 9, 2025 | |
| ONC BeOne Medicines AG | Maintained: Buy | $420 | $277.12 | +51.56% | 2 | Nov 25, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintained: Buy | $27 → $30 | $40.50 | -25.93% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $5 | $0.4333 | +1,053.93% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $1.90 | +268.42% | 1 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $20.00 | -60.00% | 1 | Sep 30, 2025 |
Viridian Therapeutics
Feb 26, 2026
Maintained: Buy
Price Target: $44 → $45
Current: $17.32
Upside: +159.82%
Cogent Biosciences
Feb 18, 2026
Maintained: Buy
Price Target: $48
Current: $37.53
Upside: +27.90%
Ocular Therapeutix
Feb 17, 2026
Maintained: Buy
Price Target: $28
Current: $9.85
Upside: +184.26%
Incyte
Feb 11, 2026
Maintained: Buy
Price Target: $120
Current: $108.46
Upside: +10.64%
Monte Rosa Therapeutics
Jan 7, 2026
Maintained: Buy
Price Target: $31
Current: $20.85
Upside: +48.68%
ImmunityBio
Dec 12, 2025
Maintained: Buy
Price Target: $9
Current: $7.80
Upside: +15.38%
Olema Pharmaceuticals
Dec 10, 2025
Maintained: Buy
Price Target: $43
Current: $11.14
Upside: +286.00%
Kymera Therapeutics
Dec 9, 2025
Maintained: Buy
Price Target: $73 → $122
Current: $99.87
Upside: +22.16%
BeOne Medicines AG
Nov 25, 2025
Maintained: Buy
Price Target: $420
Current: $277.12
Upside: +51.56%
Centessa Pharmaceuticals
Nov 13, 2025
Maintained: Buy
Price Target: $27 → $30
Current: $40.50
Upside: -25.93%
Nov 4, 2025
Maintained: Buy
Price Target: $6 → $5
Current: $0.4333
Upside: +1,053.93%
Oct 8, 2025
Maintained: Buy
Price Target: $7
Current: $1.90
Upside: +268.42%
Sep 30, 2025
Downgraded: Hold
Price Target: $8
Current: $20.00
Upside: -60.00%